港股异动丨折让48%供股！永泰生物一度跌超16%

Core Viewpoint - Yongtai Bio (6978.HK) experienced a significant intraday drop of over 16%, trading at HKD 3.98, following the announcement of a proposed 5-for-1 rights issue at a subscription price of HKD 2.5 per share, representing a 47.7% discount from the pre-suspension price of HKD 4.78 [1] Fundraising Details - The company aims to raise a maximum of HKD 308 million through the rights issue [1] - Approximately 54% of the net proceeds will be allocated to EAL clinical trials [1] - About 24% will be used to expand research and development expenditures for other clinical indications of EAL [1] - The remaining 22% is designated for general working capital [1]